Ceruloplasmin— 510(k) K161508

Substantially Equivalent

Beckman Coulter Ireland, Inc.

FDA 510(k) clearance K161508 for Ceruloplasmin, Substantially Equivalent on 2017-01-09. Applicant: Beckman Coulter Ireland, Inc..

Clearance details

Applicant: Beckman Coulter Ireland, Inc.
Product code: Code DDB
Advisory panel: Immunology
Date received: 2016-06-01
Decision date: 2017-01-09
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Co. Clare, IE

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.